The novel phospho-non-steroidal anti-inflammatory drugs, OXT-328, MDC-22 and MDC-917, inhibit adjuvant-induced arthritis in rats.
about
Phospho-aspirin-2 (MDC-22) inhibits estrogen receptor positive breast cancer growth both in vitro and in vivo by a redox-dependent effectPhospho-ibuprofen (MDC-917) is a novel agent against colon cancer: efficacy, metabolism, and pharmacokinetics in mouse models.Phospho-sulindac (OXT-328) combined with difluoromethylornithine prevents colon cancer in mice.Phospho-aspirin (MDC-22) inhibits breast cancer in preclinical animal models: an effect mediated by EGFR inhibition, p53 acetylation and oxidative stressTopically applied phospho-sulindac hydrogel is efficacious and safe in the treatment of experimental arthritis in rats.Sterically stabilized liposomes incorporating the novel anticancer agent phospho-ibuprofen (MDC-917): preparation, characterization, and in vitro/in vivo evaluationChemotherapeutic properties of phospho-nonsteroidal anti-inflammatory drugs, a new class of anticancer compounds.Carboxylesterases 1 and 2 hydrolyze phospho-nonsteroidal anti-inflammatory drugs: relevance to their pharmacological activity.The metabolism and pharmacokinetics of phospho-sulindac (OXT-328) and the effect of difluoromethylornithine.Phospho-ibuprofen (MDC-917) incorporated in nanocarriers: anti-cancer activity in vitro and in vivo.Regioselective oxidation of phospho-NSAIDs by human cytochrome P450 and flavin monooxygenase isoforms: implications for their pharmacokinetic properties and safety.Phospho-ibuprofen (MDC-917) suppresses breast cancer growth: an effect controlled by the thioredoxin system.Topical phospho-sulindac (OXT-328) is effective in the treatment of non-melanoma skin cancer.Phospho-sulindac (OXT-328) inhibits the growth of human lung cancer xenografts in mice: enhanced efficacy and mitochondria targeting by its formulation in solid lipid nanoparticles.In vitro and in vivo metabolic studies of phospho-aspirin (MDC-22)The anticancer effect of phospho-tyrosol-indomethacin (MPI-621), a novel phosphoderivative of indomethacin: in vitro and in vivo studiesPhosphosulindac (OXT-328) selectively targets breast cancer stem cells in vitro and in human breast cancer xenograftsPhospho-Aspirin (MDC-22) Prevents Pancreatic Carcinogenesis in Mice.A novel Ras inhibitor (MDC-1016) reduces human pancreatic tumor growth in miceProdrugs of nonsteroidal anti-inflammatory drugs (NSAIDs), more than meets the eye: a critical review.Recent developments in chimeric NSAIDs as safer anti-inflammatory agents.Nonsteroidal Anti-Inflammatory Therapy: A Journey Toward Safety.A novel NSAID derivative, phospho-ibuprofen, prevents AOM-induced colon cancer in rats.7,3'-dimethoxy hesperetin inhibits inflammation by inducing synovial apoptosis in rats with adjuvant-induced arthritis.Therapeutic effect of acetazolamide, an aquaporin 1 inhibitor, on adjuvant-induced arthritis in rats by inhibiting NF-κB signal pathway.Investigation of chronic efficacy and safety profile of two potential anti-inflammatory bipyrazole-based compounds in experimental animals.Synthesis and Anticancer Activities of 4-[(Halophenyl)diazenyl]phenol and 4-[(Halophenyl)diazenyl]phenyl Aspirinate Derivatives against Nasopharyngeal Cancer Cell Lines
P2860
Q28544712-F8FE5885-669E-4876-B0A2-3F707C771D65Q35003113-8E26A16A-ABA3-4D01-938E-2FB2EAAFC9E4Q35091403-08FB00D4-353F-447B-AFC2-33C4A44BE4D7Q35103873-D5EB1650-7AA6-455D-824E-4053B67D4FAEQ35388614-EFB650F3-29AD-4C29-AAB0-498FA07BE3C7Q35597041-371B68B4-A34E-4DD9-8C0B-B301BFBC4D68Q35624238-C0F87310-F5D9-4F1E-A659-3EAC666AA18AQ35688543-2B866A0A-D682-43E7-8AEB-0C92F0CB1D67Q36147300-62E3DFB2-A380-45B6-9AED-2A64A77778FFQ36158947-FB429D91-FB94-430C-A2B3-3CD265AD7C67Q36252867-6E2D56B3-A951-4098-84C0-DB49EDE1E080Q36393171-671D2DEA-11B3-436C-9EDF-15D062E61597Q36642853-E266960D-9429-41E5-9E0D-0FA13B49196CQ36645178-7D91F692-E469-4F12-A53C-B60A7BB845ABQ36700587-392DA19E-94A9-486B-AE47-C86BE02FD952Q36740696-C81A86CB-A0CE-443B-97F5-4B1330F9571DQ36752069-12D7E670-EB57-48F1-9BD0-F6C26D8FC155Q37059925-4750B409-BC48-46DD-8F21-E86A393143BBQ37285560-A04CDDF7-12FF-44F8-865E-6C590123CF1EQ38068081-5EFE654E-708C-4AC5-91D1-5DE85272A82FQ38260626-29C1B11E-ED94-4F8E-AE75-3C59F6962AE9Q38558587-0FD9638A-6BA7-41A9-80CC-317209B38492Q38695691-F17C8B6F-81E8-4206-9939-7D7C4842FBFEQ43687760-E6E2D61C-C0CD-4BE6-A16A-A221236E4A2CQ47230514-01B078B5-E8AF-4CFA-8E4B-73926F34508CQ52584469-D29210A6-97BA-43F4-9CA5-21B5A03AF73BQ59145963-DADFD76D-A925-4B44-9054-E2E3AB55C1D7
P2860
The novel phospho-non-steroidal anti-inflammatory drugs, OXT-328, MDC-22 and MDC-917, inhibit adjuvant-induced arthritis in rats.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The novel phospho-non-steroida ...... ant-induced arthritis in rats.
@ast
The novel phospho-non-steroida ...... ant-induced arthritis in rats.
@en
The novel phospho-non-steroida ...... ant-induced arthritis in rats.
@nl
type
label
The novel phospho-non-steroida ...... ant-induced arthritis in rats.
@ast
The novel phospho-non-steroida ...... ant-induced arthritis in rats.
@en
The novel phospho-non-steroida ...... ant-induced arthritis in rats.
@nl
prefLabel
The novel phospho-non-steroida ...... ant-induced arthritis in rats.
@ast
The novel phospho-non-steroida ...... ant-induced arthritis in rats.
@en
The novel phospho-non-steroida ...... ant-induced arthritis in rats.
@nl
P2093
P2860
P1476
The novel phospho-non-steroida ...... ant-induced arthritis in rats.
@en
P2093
D Komninou
Gg Mackenzie
P2860
P304
P356
10.1111/J.1476-5381.2010.01162.X
P407
P577
2011-04-01T00:00:00Z